ABCA1 and atherosclerosis: Overall, the current investigation demonstrates that PBMT, a non‐invasive treatment, can ameliorate WD‐induced atherosclerosis through promoting the ABCA1‐medicated cholesterol efflux to inhibit foam cells formation.